Evidence map›Paper›PMID 32533388›Full record

ArticlePurinergic signalling2020

Pannexin-1 channel "fuels" by releasing ATP from bone marrow cells a state of sterile inflammation required for optimal mobilization and homing of hematopoietic stem cells.

Monika Cymer, Katarzyna Brzezniakiewicz-Janus, Kamila Bujko, Arjun Thapa, Janina Ratajczak, Krzysztof Anusz, Michał Tracz, Agnieszka Jackowska-Tracz, Mariusz Z Ratajczak, Mateusz Adamiak

Open access · hybridAbstract read
In one paragraph

Article in Purinergic signalling, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. PMEnvironmental science and pollution research international · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Monika CymerCenter for Preclinical Studies and Technology, Department of Regenerative Medicine, Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091, Warsaw, Poland.
Katarzyna Brzezniakiewicz-JanusDepartment of Hematology, Multi-specialist Hospital Gorzow Wlkp, University of Zielona Gora, Zielona Gora, Poland.
Kamila BujkoStem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Arjun ThapaStem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Janina RatajczakStem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Krzysztof AnuszInstitute of Veterinary Medicine, Department of Food Hygiene and Public Health Protection, Warsaw University of Life Sciences (WULS-SGGW), Warsaw, Poland.
Michał TraczInstitute of Veterinary Medicine, Department of Food Hygiene and Public Health Protection, Warsaw University of Life Sciences (WULS-SGGW), Warsaw, Poland.
Agnieszka Jackowska-TraczInstitute of Veterinary Medicine, Department of Food Hygiene and Public Health Protection, Warsaw University of Life Sciences (WULS-SGGW), Warsaw, Poland.
Mariusz Z RatajczakCenter for Preclinical Studies and Technology, Department of Regenerative Medicine, Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091, Warsaw, Poland.
Mateusz AdamiakCenter for Preclinical Studies and Technology, Department of Regenerative Medicine, Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091, Warsaw, Poland. mateusz.adamiak@wum.edu.pl.ORCID 0000-0002-3228-9588
University of Louisville · USWarsaw University of Life Sciences · PLMedical University of Warsaw · PLUniversity of Zielona Góra · PL

Funding

Novel mechanisms involving complement cascade in stem cell traffickingR01DK074720 · NIDDK · UNIVERSITY OF LOUISVILLE · PI RATAJCZAK, MARIUSZ Z · 2007 to 2020
$4.1M
Current Trends in Stem Cell TherapiesT32HL134644 · NHLBI · UNIVERSITY OF LOUISVILLE · PI KAKAR, SHAM S., RATAJCZAK, MARIUSZ Z · 2017 to 2021
$1.4M
NHLBI NIH HHS T32 HL134644NIDDK NIH HHS R01 DK074720NIH HHS 2R01 DK074720NIH HHS T32 HL134644
6 · The paper itself

Abstract

An efficient harvest of hematopoietic stem/progenitor cells (HSPCs) after pharmacological mobilization from the bone marrow (BM) into peripheral blood (PB) and subsequent proper homing and engraftment of these cells are crucial for clinical outcomes from hematopoietic transplants. Since extracellular adenosine triphosphate (eATP) plays an important role in both processes as an activator of sterile inflammation in the bone marrow microenvironment, we focused on the role of Pannexin-1 channel in the secretion of ATP to trigger both egress of HSPCs out of BM into PB as well as in reverse process that is their homing to BM niches after transplantation into myeloablated recipient. We employed a specific blocking peptide against Pannexin-1 channel and noticed decreased mobilization efficiency of HSPCs as well as other types of BM-residing stem cells including mesenchymal stroma cells (MSCs), endothelial progenitors (EPCs), and very small embryonic-like stem cells (VSELs). To explain better a role of Pannexin-1, we report that eATP activated Nlrp3 inflammasome in Gr-1

Indexed as

Adenosine TriphosphateAnimalsBone MarrowBone Marrow CellsConnexinsHematopoietic Stem CellsInflammasomesInflammationMiceNerve Tissue ProteinsAdenosine TriphosphateConnexinsInflammasomesNerve Tissue ProteinsPanx1 protein, mouseComplement cascadeExtracellular ATPNlrp3 purinergic signalingPannexin-1Stem cell engraftmentStem cell homingStem cell mobilization

Identifiers

PMID32533388
PMCPMC7524928
OpenAlexW3035697581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.